Correlation Between Gabelli Healthcare and Dreyfus/the Boston

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Gabelli Healthcare and Dreyfus/the Boston at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gabelli Healthcare and Dreyfus/the Boston into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Gabelli Healthcare and Dreyfusthe Boston Pany, you can compare the effects of market volatilities on Gabelli Healthcare and Dreyfus/the Boston and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gabelli Healthcare with a short position of Dreyfus/the Boston. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gabelli Healthcare and Dreyfus/the Boston.

Diversification Opportunities for Gabelli Healthcare and Dreyfus/the Boston

-0.71
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Gabelli and Dreyfus/the is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding The Gabelli Healthcare and Dreyfusthe Boston Pany in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dreyfusthe Boston Pany and Gabelli Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Gabelli Healthcare are associated (or correlated) with Dreyfus/the Boston. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dreyfusthe Boston Pany has no effect on the direction of Gabelli Healthcare i.e., Gabelli Healthcare and Dreyfus/the Boston go up and down completely randomly.

Pair Corralation between Gabelli Healthcare and Dreyfus/the Boston

Assuming the 90 days horizon Gabelli Healthcare is expected to generate 142.24 times less return on investment than Dreyfus/the Boston. But when comparing it to its historical volatility, The Gabelli Healthcare is 1.75 times less risky than Dreyfus/the Boston. It trades about 0.0 of its potential returns per unit of risk. Dreyfusthe Boston Pany is currently generating about 0.34 of returns per unit of risk over similar time horizon. If you would invest  3,881  in Dreyfusthe Boston Pany on September 3, 2024 and sell it today you would earn a total of  420.00  from holding Dreyfusthe Boston Pany or generate 10.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

The Gabelli Healthcare  vs.  Dreyfusthe Boston Pany

 Performance 
       Timeline  
The Gabelli Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days The Gabelli Healthcare has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Dreyfusthe Boston Pany 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Dreyfusthe Boston Pany are ranked lower than 18 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak technical and fundamental indicators, Dreyfus/the Boston showed solid returns over the last few months and may actually be approaching a breakup point.

Gabelli Healthcare and Dreyfus/the Boston Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Gabelli Healthcare and Dreyfus/the Boston

The main advantage of trading using opposite Gabelli Healthcare and Dreyfus/the Boston positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gabelli Healthcare position performs unexpectedly, Dreyfus/the Boston can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dreyfus/the Boston will offset losses from the drop in Dreyfus/the Boston's long position.
The idea behind The Gabelli Healthcare and Dreyfusthe Boston Pany pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device